Liraglutide Injection Prefilled Pen 18 mg/3 mL (6 mg/mL) (2-Prefilled Injectors) ***Refrigeration Required***

Generic Victoza Liraglutide Injection Prefilled Pen. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist.

Teva Liraglutide Injection Prefilled Pen is a prescription medication used to improve blood sugar control in adults with type 2 diabetes. It contains the active ingredient liraglutide and is available in the strength of 18 mg/3 mL (6 mg/mL). The medication is administered through a pre-filled pen, which contains two separate pre-filled injectors. The pen is designed for subcutaneous injection, meaning it is injected just under the skin. Teva Liraglutide Injection helps to decrease blood sugar levels by stimulating the production of insulin and reducing the production of glucose from the liver. It is intended for use in conjunction with diet and exercise to help manage type 2 diabetes.

What is a GLP-1 receptor agonist?

GLP-1 receptor agonists are a type of medication commonly used for the treatment of type 2 diabetes. They work by mimicking the action of glucagon-like peptide-1 (GLP-1), a hormone that is naturally produced by the body to regulate blood sugar levels. GLP-1 receptor agonists stimulate the pancreas to produce insulin, reduce the production of glucose by the liver, and slow down the rate at which food is digested. This leads to lower blood sugar levels and better control of diabetes. Additionally, GLP-1 receptor agonists also promote weight loss and can have beneficial effects on heart health. They are typically administered through injections or inhaled through a nasal spray. Examples of GLP-1 receptor agonists include exenatide, liraglutide, and dulaglutide.

Dosage and Administration:

Adult Patients: Initiate at 0.6 mg injected subcutaneously once daily for one week then increase to 1.2 mg daily. If additional glycemic control is required, increase the dose to 1.8 mg daily after one week of treatment with the 1.2 mg daily dose (2.1).

Pediatric Patients: Initiate at 0.6 mg injected subcutaneously once daily for at least one week. If additional glycemic control is required increase the dose to 1.2 mg daily and if additional glycemic control is still required, increase the dose to 1.8 mg daily after at least one week of treatment with the 1.2 mg daily dose (2.1).

Inspect visually prior to each injection. Only use if solution is clear, colorless, and contains no particles (2.3).

Inject liraglutide subcutaneously once-daily at any time of day, independently of meals, in the abdomen, thigh or upper arm (2.3).

When using liraglutide with insulin, administer as separate injections. Never mix.

Buy Liraglutide Injection Prefilled Pen syringes and weight loss injection medications here at Mountainside Medical Equipment.